Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lacer is a prominent Spanish pharmaceutical and consumer health company headquartered in Barcelona. Founded in 1949, the company has established itself as a market leader in Spain, particularly in the oral healthcare sector with its flagship Lacer brand. Beyond oral hygiene, Lacer maintains a diverse portfolio that includes well-known consumer brands such as Pilexil for hair loss and Thrombocid for vascular health, as well as a range of prescription medicines for cardiovascular and gastrointestinal conditions. In 2022, the company was acquired by the Italian pharmaceutical group Italfarmaco, a move intended to bolster Italfarmaco's presence in the Iberian Peninsula and expand Lacer's international distribution. Lacer operates its own manufacturing and R&D facilities, focusing on high-quality formulations and specialized therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lacer Personal Health.